First degree AV block screening

Revision as of 03:10, 15 January 2020 by Aelsaiey (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

First degree AV block Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating First degree AV block from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

First degree AV block screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of First degree AV block screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on First degree AV block screening

CDC on First degree AV block screening

First degree AV block screening in the news

Blogs on First degree AV block screening

Directions to Hospitals Treating First degree AV block

Risk calculators and risk factors for First degree AV block screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

There is insufficient evidence to recommend routine screening for first degree AV block. However, screening for congenital AV block is recommended.

Screening

  • There is insufficient evidence to recommend routine screening for first degree AV block. However, screening for congenital AV block is recommended.
  • Recommendations include echocardiogram for newborns of pregnant women with SSA autoantiboides.
  • Timing for screening:[1]
    • Women with history of neonatal lupus, fetal Echos are recommended weekly then repeating the Echos every 3 or 4 weeks.
    • Women with prior infant with lupus, Echos are performed at the 16 weeks of gestation or 18 weeks.
  • Fetal Echos can be stopped by the 23 weeks of gestation.

References

  1. Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). "The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices". Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.